Dendritic cell-based cancer vaccines
tumor antigen-specific killer CD8+ T cells
eDC-activated, highly cytotoxic NK cells
eDC-activated, highly cytotoxic Tgammadelta cells
Engineered DC exosome
CD1d-expressing eDC-activated NKT cells
1/6
1/5
1/3
Copyright © 2021 Dendritic Cell Immunotherapy - All Rights Reserved.